What is the Anthem Biosciences Ltd share price today?

The share price of NSE:ANTHEM-EQ on 01 Oct 2026 (as of 15:03:02 IST) is ₹849.6.

What is the NSE:ANTHEM-EQ 52 week high low price?

Over the past 52 weeks (as of 01 Oct 2026), the NSE:ANTHEM-EQ 52 week high low range shows a high of ₹977.55 and a low of ₹579.15.

What is the Anthem Biosciences Ltd market cap?

As on 01 Oct 2026, Anthem Biosciences Ltd market cap is ₹483113000000.

What is the shareholding pattern of Anthem Biosciences Ltd Stock?

The shareholding pattern of Anthem Biosciences Ltd, as of last reported-on 30 Jun 2026 is: Promoters: 71.42% Foreign Institutional Investors (FII): 2.57% Domestic Institutional Investors (DII): 2.33% Mutual Funds: 11.15% Retail & Others: 12.53% This demonstrates an outstanding distribution of ownership.

What are the PE and PB ratios of Anthem Biosciences Ltd?

The Price-to-Earnings (PE) ratio of Anthem Biosciences Ltd is 83.8819, and the Price-to-Book (PB) ratio is 12.2509, as on 01 Oct 2026.

Anthem Biosciences Share Price

854.45+18.95 (+2.27%)

+21.53% past 1 Year

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

1 Day

+2.27%

1 Week

+3.09%

1 Month

+0.30%

3 Month

+3.49%

6 Month

+8.90%

YTD

+31.15%

1 Year

+21.53%

5 Year

10 Year

Max

+18.17%

YTD

10Y

MAX

Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.

Price Analysis

1 Day

1 Week

1 Month

3 Months

6 Months

1 Year

Low

831.60

823.05

783.35

732.00

579.15

High

860.00

898.65

977.55

About

Anthem Biosciences is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing with integrated New Chemical Entity Read more

Pharmaceuticals & Drugs

Midcap

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats

1. Premium insight available after login

2. Sign in to view full SWOT analysis

3. Unlock strengths, weaknesses, opportunities & threats

QVT

Quality

0/100-

Valuation

0/100-

Technical

0/100-

Peer Stocks

1 week

1 month

1 year

Name

SUNPHARMANSE

DIVISLABNSE

TORNTPHARMNSE

LAURUSLABSNSE

ZYDUSLIFENSE

DRREDDYNSE

CIPLANSE

MANKINDNSE

AUROPHARMANSE

LUPINNSE

ANTHEMNSE

LTP

1W Low

1W High

Market cap (₹)

1769.9+8.9 (0.51%)

1722

1855

4,24,202Cr

10064+400 (4.14%)

9621.50

10064

2,64,141Cr

4650+70 (1.53%)

4532

4675

1,74,402Cr

2323+79 (3.52%)

2206.10

2441.90

1,26,811Cr

1240.6+56.2 (4.75%)

1182

1254.20

1,23,685Cr

1368.3+23.3 (1.73%)

1336.70

1368.30

1,11,868Cr

1396.9+38.9 (2.86%)

1357

1396.90

1,11,650Cr

2475+5.7 (0.23%)

2457.90

2528

1,02,196Cr

1694.5+34.6 (2.08%)

1647.20

1697.40

96,951Cr

2015.9+26 (1.31%)

1974

2033.80

91,301Cr

854.45+24.3 (2.93%)

823.05

860

47,367Cr

Anthem Biosciences Share Price

854.45+18.95 (+2.27%)

+21.53% past 1 Year

Financial overview

Compounded Sales Growth

10 years32%

5 years14%

3 years26%

Last year15%

Compounded Profit Growth

10 years43%

5 years17%

3 years15%

Last year31%

Stock Price CAGR

10 years-

5 years-

3 years-

1 year22%

Return on Equity

10 years33%

5 years25%

3 years21%

Last year22%

CAGR%

Sales

Profits

Returns

ROE

10Y	5Y	3Y	TTM
32%	14%	26%	15%
43%	17%	15%	31%
-	-	-	22%
33%	25%	21%	22%

Peer Comparison

Symbol

SUNPHARMA

DIVISLAB

TORNTPHARM

LAURUSLABS

ZYDUSLIFE

DRREDDY

CIPLA

MANKIND

AUROPHARMA

LUPIN

ANTHEM

Price	M.Cap (₹)	PE Ratio	EPS (₹)	EV/EBITDA	Annual PAT
1,769.9	₹424202 Cr	38.68	8.29	58.23	₹11479 Cr
10,064	₹264141 Cr	90.3	34.04	128.41	₹2568 Cr
4,650	₹174402 Cr	82.11	14.04	106.21	₹2163 Cr
2,323	₹126811 Cr	94.64	8.17	33.94	₹889 Cr
1,240.6	₹123685 Cr	27.41	9.42	62.53	₹5040 Cr
1,368.3	₹111868 Cr	39.95	11.08	59.2	₹4196 Cr
1,396.9	₹111650 Cr	38.54	10.86	52.6	₹3879 Cr
2,475	₹102196 Cr	45.57	17.23	76.26	₹1913 Cr
1,694.5	₹96951 Cr	26.11	17.95	96.84	₹3505 Cr
2,015.9	₹91301 Cr	16.51	30.95	154.35	₹5333 Cr
854.45	₹47367 Cr	82.24	2.13	12.66	₹592 Cr

Profit & Loss

Consolidated

Standalone

Quarterly

Yearly

₹

Name

Net Revenue

Other Income

Total Revenue

Total Expenditure

Operating Profit

Interest Expense

PBT

Net Profit

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024
₹594 Cr	₹418 Cr	₹611 Cr	₹423 Cr	₹551 Cr	₹540 Cr	₹483 Cr	₹498 Cr	₹525 Cr	₹339 Cr
₹59 Cr	₹25 Cr	₹51 Cr	₹34 Cr	₹48 Cr	₹23 Cr	₹14 Cr	₹24 Cr	₹28 Cr	₹19 Cr
₹653 Cr	₹443 Cr	₹662 Cr	₹457 Cr	₹598 Cr	₹563 Cr	₹497 Cr	₹522 Cr	₹553 Cr	₹358 Cr
₹353 Cr	₹298 Cr	₹383 Cr	₹300 Cr	₹366 Cr	₹375 Cr	₹318 Cr	₹359 Cr	₹350 Cr	₹236 Cr
₹330 Cr	₹175 Cr	₹318 Cr	₹191 Cr	₹266 Cr	₹214 Cr	₹209 Cr	₹184 Cr	₹223 Cr	₹140 Cr
₹3 Cr	₹89 L	₹2 Cr	₹35 L	₹3 Cr	₹2 Cr	₹52 L	₹3 Cr	₹4 Cr	₹4 Cr
₹296 Cr	₹145 Cr	₹278 Cr	₹130 Cr	₹230 Cr	₹186 Cr	₹178 Cr	₹161 Cr	₹200 Cr	₹118 Cr
₹211 Cr	₹120 Cr	₹190 Cr	₹93 Cr	₹173 Cr	₹136 Cr	₹83 Cr	₹124 Cr	₹162 Cr	₹82 Cr

Balance Sheet

Consolidated

Standalone

₹

Name

Equity And Liabilities

Share Capital

Share Warrants & Outstandings

Total Reserves

Reserve excluding Revaluation Reserve

Shareholder's Funds

Minority Interest

Secured Loans

Unsecured Loans

Deferred Tax Assets / Liabilities

Other Long Term Liabilities

Long Term Trade Payables

Long Term Provisions

Total Non-Current Liabilities

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Current Liabilities

Total Liabilities

Contingent Liabilities

Total Debt

Assets

Gross Block

Less Accumulated Depreciation

Net Block

Capital Work in Progress

Non Current Investments

Long Term Investment

Long Term Loans & Advances

Other Non Current Assets

Total Non-Current Assets

Current Assets Loans & Advances

Currents Investments

Inventories

Sundry Debtors

Cash and Bank

Other Current Assets

Short Term Loans and Advances

Total Current Assets

Net Current Assets (Including Current Investments)

Total Assets

Book Value

Adjusted Book Value

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
—	—	—	—	—	—	—	—	—	—	—	—
₹112 Cr	₹112 Cr	₹112 Cr	₹114 Cr	₹9 Cr	₹8 Cr	₹8 Cr	₹11 Cr	₹13 Cr	₹13 Cr	₹13 Cr	₹8 Cr
₹33 Cr	₹34 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹2897 Cr	₹2264 Cr	₹1813 Cr	₹1627 Cr	₹1346 Cr	₹693 Cr	₹413 Cr	₹213 Cr	₹138 Cr	₹89 Cr	₹50 Cr	₹30 Cr
₹2897 Cr	₹2264 Cr	₹1813 Cr	₹1627 Cr	₹1346 Cr	₹693 Cr	₹413 Cr	₹213 Cr	₹138 Cr	₹89 Cr	₹50 Cr	₹30 Cr
₹3043 Cr	₹2410 Cr	₹1925 Cr	₹1741 Cr	₹1355 Cr	₹701 Cr	₹422 Cr	₹223 Cr	₹151 Cr	₹102 Cr	₹64 Cr	₹38 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹11 L	₹8 L	₹4 L	₹0
₹28 Cr	₹47 Cr	₹112 Cr	₹96 Cr	₹6 Cr	₹20 Cr	₹76 Cr	₹124 Cr	₹55 Cr	₹20 Cr	₹14 Cr	₹14 Cr
₹0	₹0	₹0	₹0	₹0	₹0	₹20 Cr	₹32 Cr	₹28 Cr	₹30 Cr	₹32 Cr	₹5 Cr
-₹27 Cr	-₹18 Cr	-₹41 Cr	-₹25 Cr	-₹16 Cr	-₹14 Cr	-₹12 Cr	₹5 L	-₹79 L	₹1 Cr	₹73 L	-₹89 L
₹17 Cr	₹17 Cr	₹17 Cr	₹8 Cr	₹27 Cr	₹20 Cr	₹16 Cr	₹0	₹54 L	₹1 Cr	₹44 L	₹87 L
₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹37 L	₹50 L	₹32 L
₹16 Cr	₹8 Cr	₹7 Cr	₹5 Cr	₹5 Cr	₹7 Cr	₹7 Cr	₹4 Cr	₹3 Cr	₹3 Cr	₹1 Cr	₹94 L
₹34 Cr	₹54 Cr	₹93 Cr	₹85 Cr	₹22 Cr	₹34 Cr	₹107 Cr	₹160 Cr	₹86 Cr	₹57 Cr	₹49 Cr	₹21 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹75 Cr	₹110 Cr	₹101 Cr	₹72 Cr	₹65 Cr	₹77 Cr	₹58 Cr	₹33 Cr	₹26 Cr	₹24 Cr	₹29 Cr	₹13 Cr
₹188 Cr	₹146 Cr	₹107 Cr	₹54 Cr	₹109 Cr	₹102 Cr	₹162 Cr	₹53 Cr	₹29 Cr	₹12 Cr	₹7 Cr	₹6 Cr
₹4 Cr	₹43 Cr	₹121 Cr	₹29 Cr	₹30 Cr	₹80 Cr	₹26 Cr	₹35 Cr	₹37 Cr	₹27 Cr	₹29 Cr	₹21 Cr
₹262 Cr	₹186 Cr	₹130 Cr	₹124 Cr	₹145 Cr	₹97 Cr	₹1 Cr	₹5 Cr	₹27 Cr	₹13 Cr	₹4 Cr	₹3 Cr
₹530 Cr	₹485 Cr	₹459 Cr	₹279 Cr	₹349 Cr	₹356 Cr	₹247 Cr	₹126 Cr	₹119 Cr	₹76 Cr	₹69 Cr	₹43 Cr
₹3606 Cr	₹2949 Cr	₹2477 Cr	₹2105 Cr	₹1726 Cr	₹1091 Cr	₹776 Cr	₹510 Cr	₹355 Cr	₹235 Cr	₹181 Cr	₹102 Cr
₹90 Cr	₹54 Cr	₹250 Cr	₹226 Cr	₹6 Cr	₹11 Cr	₹8 Cr	₹0	₹0	₹0	₹9 Cr	₹6 Cr
₹51 Cr	₹109 Cr	₹233 Cr	₹125 Cr	₹35 Cr	₹100 Cr	₹159 Cr	₹191 Cr	₹119 Cr	₹77 Cr	₹74 Cr	₹40 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹1507 Cr	₹1300 Cr	₹996 Cr	₹884 Cr	₹703 Cr	₹682 Cr	₹567 Cr	₹346 Cr	₹153 Cr	₹136 Cr	₹123 Cr	₹64 Cr
₹723 Cr	₹595 Cr	₹514 Cr	₹435 Cr	₹374 Cr	₹321 Cr	₹261 Cr	₹88 Cr	₹67 Cr	₹45 Cr	₹35 Cr	₹27 Cr
₹783 Cr	₹705 Cr	₹483 Cr	₹449 Cr	₹329 Cr	₹361 Cr	₹306 Cr	₹258 Cr	₹86 Cr	₹91 Cr	₹87 Cr	₹37 Cr
₹264 Cr	₹297 Cr	₹345 Cr	₹164 Cr	₹154 Cr	₹19 Cr	₹50 Cr	₹43 Cr	₹74 Cr	₹22 Cr	₹6 Cr	₹17 Cr
₹342 Cr	₹121 Cr	₹13 Cr	₹6 Cr	₹4 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹342 Cr	₹121 Cr	₹13 Cr	₹6 Cr	₹4 Cr	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹50 Cr	₹29 Cr	₹35 Cr	₹47 Cr	₹22 Cr	₹24 Cr	₹17 Cr	₹8 Cr	₹13 Cr	₹12 Cr	₹9 Cr	₹4 Cr
₹159 Cr	₹150 Cr	₹81 L	₹59 L	₹79 L	₹27 L	₹40 L	₹5 Cr	₹2 Cr	₹3 Cr	₹13 L	₹9 L
₹1599 Cr	₹1301 Cr	₹875 Cr	₹666 Cr	₹510 Cr	₹404 Cr	₹373 Cr	₹316 Cr	₹176 Cr	₹128 Cr	₹102 Cr	₹58 Cr
—	—	—	—	—	—	—	—	—	—	—	—
₹666 Cr	₹312 Cr	₹459 Cr	₹493 Cr	₹269 Cr	₹209 Cr	₹99 Cr	₹27 Cr	₹8 Cr	₹2 Cr	₹5 Cr	₹0
₹125 Cr	₹340 Cr	₹211 Cr	₹129 Cr	₹58 Cr	₹35 Cr	₹125 Cr	₹58 Cr	₹47 Cr	₹37 Cr	₹31 Cr	₹15 Cr
₹591 Cr	₹450 Cr	₹490 Cr	₹274 Cr	₹326 Cr	₹255 Cr	₹105 Cr	₹74 Cr	₹84 Cr	₹57 Cr	₹31 Cr	₹10 Cr
₹275 Cr	₹172 Cr	₹184 Cr	₹343 Cr	₹349 Cr	₹41 Cr	₹22 Cr	₹11 Cr	₹4 Cr	₹2 Cr	₹3 Cr	₹2 Cr
₹7 Cr	₹10 Cr	₹3 Cr	₹3 Cr	₹10 Cr	₹4 Cr	₹5 Cr	₹11 Cr	₹8 Cr	₹6 Cr	₹86 L	₹34 L
₹344 Cr	₹362 Cr	₹253 Cr	₹196 Cr	₹204 Cr	₹143 Cr	₹46 Cr	₹13 Cr	₹29 Cr	₹4 Cr	₹8 Cr	₹16 Cr
₹2007 Cr	₹1647 Cr	₹1602 Cr	₹1438 Cr	₹1216 Cr	₹687 Cr	₹403 Cr	₹194 Cr	₹179 Cr	₹107 Cr	₹79 Cr	₹43 Cr
₹1477 Cr	₹1162 Cr	₹1143 Cr	₹1159 Cr	₹867 Cr	₹331 Cr	₹156 Cr	₹68 Cr	₹61 Cr	₹31 Cr	₹10 Cr	-₹20 L
₹3606 Cr	₹2949 Cr	₹2477 Cr	₹2105 Cr	₹1726 Cr	₹1091 Cr	₹776 Cr	₹510 Cr	₹355 Cr	₹235 Cr	₹181 Cr	₹102 Cr
₹54	₹42	₹34	₹31	₹1,544	₹827	₹503	₹264	₹174	₹116	₹70	₹50
₹54	₹42	₹34	₹31	₹24	₹13	₹8	₹4	₹3	₹2	₹1	₹1

Cash Flow

Consolidated

Standalone

₹

Name

Profit Before Tax

Adjustment

Changes In working Capital

Cash Flow after changes in Working Capital

Cash Flow from Operating Activities

Cash Flow from Investing Activities

Cash Flow from Financing Activitie

Net Cash Inflow / Outflow

Opening Cash & Cash Equivalents

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
₹824 Cr	₹657 Cr	₹477 Cr	₹497 Cr	₹546 Cr	₹366 Cr	₹121 Cr	₹0	₹0	₹0	₹0	₹0
₹85 Cr	₹73 Cr	₹45 Cr	₹27 Cr	₹49 Cr	₹77 Cr	₹76 Cr	₹0	₹0	₹0	₹0	₹0
₹139 Cr	-₹301 Cr	-₹262 Cr	-₹104 Cr	-₹139 Cr	-₹94 Cr	₹14 Cr	₹0	₹0	₹0	₹0	₹0
₹1048 Cr	₹430 Cr	₹260 Cr	₹421 Cr	₹456 Cr	₹349 Cr	₹211 Cr	₹0	₹0	₹0	₹0	₹0
₹844 Cr	₹271 Cr	₹140 Cr	₹306 Cr	₹333 Cr	₹278 Cr	₹166 Cr	₹0	₹0	₹0	₹0	₹0
-₹702 Cr	-₹147 Cr	-₹221 Cr	-₹376 Cr	-₹205 Cr	-₹196 Cr	-₹109 Cr	₹0	₹0	₹0	₹0	₹0
-₹40 Cr	-₹136 Cr	-₹77 Cr	₹64 Cr	₹181 Cr	-₹63 Cr	-₹48 Cr	₹0	₹0	₹0	₹0	₹0
₹103 Cr	-₹12 Cr	-₹158 Cr	-₹6 Cr	₹308 Cr	₹18 Cr	₹9 Cr	₹0	₹0	₹0	₹0	₹0
₹172 Cr	₹184 Cr	₹343 Cr	₹349 Cr	₹41 Cr	₹22 Cr	₹14 Cr	₹0	₹0	₹0	₹0	₹0
-₹27 L	-₹41 L	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0	₹0
₹275 Cr	₹172 Cr	₹184 Cr	₹343 Cr	₹349 Cr	₹41 Cr	₹22 Cr	₹0	₹0	₹0	₹0	₹0

Fundamental Ratios

Consolidated

Standalone

No results found

Anthem Biosciences Share Price

854.45+18.95 (+2.27%)

+21.53% past 1 Year

Shareholding summary

Promoters

71.4%

FII

3.79%

DII

2.85%

9.25%

Others

12.71%

Promoters

FII

DII

Others

Quarterly

Yearly

Shareholding Pattern

Quarterly

Yearly

Name

Promoters

FII

DII - Others

DII - MFs

Retail & Others

Sep 2026	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jul 2025
71.40%	71.42%	74.68%	74.69%	74.69%	74.69%
3.79%	2.57%	1.28%	1.37%	1.66%	1.50%
2.85%	2.33%	1.43%	0.71%	0.53%	1.38%
9.25%	11.15%	10.12%	6.89%	6.68%	2.21%
12.71%	12.53%	12.49%	16.34%	16.44%	20.22%

Bulk & block deals

Name

Portsmouth Technologies Llc

Integrated Core Strategies Asia Pte Ltd

Icici Prudential Life Insurance Company Limited

Aruna Ganesh

360 One Mutual Fund

Kotak Mahindra Life Insurance Company Limited

Bajaj Life Insurance Limited

Canara Robeco Mutual Fund

Edelweiss Mutual Fund

Ghisallo Master Fund Lp

Deal Date	Action	Deal Value	Deal Price	Qty Traded	Deal Type	%Stake Traded	Exchange
09 Oct 2026	Sell	249.90 Cr	₹833	30 L	Bulk	0.532675	BSE
18 Jun 2026	Purchase	14.90 L	₹744.80	2 K	Block	0.000355	NSE
18 Jun 2026	Purchase	90 Cr	₹744.80	12.08 L	Block	0.214558	NSE
18 Jun 2026	Sell	1,274.70 Cr	₹744.80	1.71 Cr	Bulk	3.038841	NSE
18 Jun 2026	Purchase	25 Cr	₹744.80	3.36 L	Block	0.059599	NSE
18 Jun 2026	Purchase	8 Cr	₹744.80	1.07 L	Block	0.01908	NSE
18 Jun 2026	Purchase	90 Cr	₹744.80	12.08 L	Block	0.214558	NSE
18 Jun 2026	Purchase	40 Cr	₹744.80	5.37 L	Block	0.095359	NSE
18 Jun 2026	Purchase	25 Cr	₹744.80	3.36 L	Block	0.059599	NSE
18 Jun 2026	Purchase	25 Cr	₹744.80	3.36 L	Block	0.059599	NSE

Insider trading & SAST

Client name

Viridity Tone Llp

Aruna Ganesh

Krithika Ganesh

Viridity Tone Llp

Aruna Ganesh

Reported on	Client category	Action	%Stake traded	Holding % post deal	Deal value	Deal price	Qty traded	Deal period	Deal mode	Post transaction holding	Insider/SAST	Regulation type	Security type
21 Sep 2026	Designated Person	Disposal	0.159803	0.02	82.67 Cr	₹918.60	9 L	18 Sep 2026	Market Sale	1,00,000	Insider Trading	—	Equity
16 Jul 2026	Promoter	Disposal	3.05	—	0	—	1.71 Cr	18 Jun 2026	Market	—	SAST	29(2)	—
12 Mar 2026	Promoter Group	Disposal	1.523427	0	0	—	85.57 L	09 Mar 2026	Gift	0	Insider Trading	—	Equity Shares
12 Mar 2026	Designated Person	Disposal	3.616395	0.18	1,255.25 Cr	₹617.93	2.03 Cr	09 Mar 2026	Market Sale	10,00,000	Insider Trading	—	Equity Shares
12 Mar 2026	Promoter Group	Acquisition	1.523427	3.05	0	—	85.57 L	09 Mar 2026	Gift	1,71,14,604	Insider Trading	—	Equity Shares

Anthem Biosciences Share Price

Price Analysis

Share Price Live Stats

Share Market Cap & Key Ratios Overview

About

Stock Analysis (SWOT)

QVT

Peer Stocks

Anthem Biosciences Share Price

Anthem Biosciences Share Price

Financial overview

Compounded Sales Growth

Compounded Profit Growth

Stock Price CAGR

Return on Equity

Peer Comparison

Profit & Loss

Balance Sheet

Cash Flow

Fundamental Ratios

Anthem Biosciences Share Price

Anthem Biosciences Share Price

Oscillators

Moving averages

Anthem Biosciences Share Price

Shareholding summary

Shareholding Pattern

Bulk & block deals

Insider trading & SAST

Anthem Biosciences Share Price

Corporate Actions

Company details

Anthem Biosciences Share Price

Corporate filings & documents

Announcements

Annual reports

Concalls & investor presentations

Anthem Biosciences Share Price

News

Anthem Biosciences Reports Stronger Second Quarter EBITDA And Margin

Anthem Biosciences Reports Year On Year Growth In Second Quarter Net Profit

Anthem Biosciences Reports Higher Second Quarter Revenue Growth

Anthem Biosciences Portsmouth Technologies Sells Shares In BSE Block Trade

Jefferies initiates Buy on Anthem Biosciences with Rs 1,050 target

Anthem Biosciences sees Rs 118.42 crore NSE block trade at discount

Large Anthem Biosciences BSE block trade signals institutional interest and liquidity

Anthem Biosciences management reiterates confidence in regaining mid-teens growth trajectory

Anthem Biosciences Q1 EBITDA declines year-on-year with margin contraction

Anthem Biosciences reports Q1 revenue of Rs 384 crore versus Rs 538 crore year on year

Anthem Biosciences Q1 net profit falls to Rs 102 crore versus last year

Anthem Biosciences informs about newspaper publication

Anthem Biosciences posted stronger Q4 EBITDA and improved operating margin YoY

Anthem Biosciences reported strong Q4 results with robust profit growth

Anthem Biosciences reports Profit after tax of 211.66 Crores, in the March 2026 quarter

Citigroup initiates Buy on Anthem Biosciences with Rs 870 target, highlights CRDMO growth.

Anthem Biosciences - Quaterly Results

Anthem Biosciences reports Profit after tax of 112.13 Crores, in the December 2025 quarter

Anthem Biosciences Q3 EBITDA Slightly Down YoY but Margin Expands to 37.15%.

Anthem Biosciences Reports Q3 Revenue of Rs 420 Crores, Down from Rs 500 Crores YoY.

Anthem Biosciences Ltd Share Price Today

Anthem Biosciences Quick Links

Other Stocks

Calculators

Brokerage Calculator

Stock Average Calculator

MTF Calculator

Margin Calculator

Span Margin Calculator